Cite
HARVARD Citation
Carlson, C. et al. (n.d.). P2‐007: Exposure‐Adjusted Analysis of Treatment‐Emergent Adverse Events from Expedition and Expedition2 Trials of Solanezumab for The Treatment of Alzheimer's Disease. Alzheimer's & dementia. pp. P610-P611. [Online].